The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study.
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/07/210721141945.htm
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/07/210721141945.htm
Ibrutinib effective treatment for difficult-to-treat forms of hairy cell leukemia, study finds
Reviewed by cmakigo
on
July 22, 2021
Rating:
No comments:
Post a Comment